the aid library

временное руководство. Первый выпуск: 10 февраля 2021 г. Обновлено: 21 апреля 2021 г. Последнее обновление 30 июля 2021г.

Interim recommendations for the use of ChAdOx1-S [recombinant] COVID-19 vaccine (AstraZeneca COVID-19 AZD1222 Vaxzevria™, SII COVISHIELD™ vaccine) - Last updated 30 July 2021

Guidance for clinical case management of thrombosis syndrome with thrombocytopenia (TTS) following vaccination to prevent coronavirus disease (COVID-19) Interim guidance 19 July 2021

Предварительные рекомендации по применению вакцины ChAdOx1-S [‎рекомбинантной]‎ против COVID-19 (‎вакцина AstraZeneca COVID-19 AZD1222, Vaxzevria™, SII COVISHIELD™)
recommended

Recomendações provisórias para o uso da vacina ChAdOx1-S [recombinante] contra COVID-19 (vacina AstraZeneca COVID-19 AZD1222 Vaxzevria™, SII COVISHIELD™) - Última atualização em 30 de julho de 2021

AstraZeneca’s COVID-19 vaccine: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets

Recommandations provisoires concernant l’utilisation du vaccin ChAdOx1-S [‎recombinant]‎ contre la COVID-19 (‎vaccin anti-COVID-19 AZD1222 Vaxzevria™ d’AstraZeneca, COVISHIELD™ de SII)‎
recommended

Guidance for clinical case management of thrombosis with thrombocytopenia syndrome‎ following vaccination to prevent coronavirus disease (‎COVID-19)‎ (Arabic)

Guidance for clinical case management of thrombosis with thrombocytopenia syndrome (‎TTS)‎ following vaccination to prevent coronavirus disease (‎COVID-19)‎: interim guidance, 19 July 2021

Orientação para manejo de caso clínico de síndrome de trombose com trombocitopenia (TTS) após vacinação para prevenir doença por coronavírus (COVID-19) Orientação provisória 19 julho 2021

Orientations sur la prise en charge clinique du syndrome de thrombose-thrombocytopénie (TTS) après la vaccination contre la maladie à coronavirus 2019 (COVID-19)

Предварительные рекомендации по применению вакцины ChAdOx1-S [‎рекомбинантной]‎ против COVID-19 (‎вакцина AstraZeneca COVID-19 AZD1222, Vaxzevria™, SII COVISHIELD™) recommended